Novanta Inc (NAS:NOVT)
$ 152.98 -1.76 (-1.14%) Market Cap: 5.50 Bil Enterprise Value: 5.98 Bil PE Ratio: 92.16 PB Ratio: 7.40 GF Score: 93/100

Novanta Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 11:45PM GMT
Release Date Price: $142.36 (+2.57%)
Raji Gunasekera

Good afternoon. My name is Raji Gunasekera. I'm an associate on the healthcare team at JPMorgan. I'm pleased to introduce the CEO of Novanta, Matthijs Glastra with me here today. Thank you.

Matthijs Glastra
Novanta Inc. - CEO & Chairman of the Board

Thank you. Good afternoon, everybody. It's great to be at the JPMorgan Healthcare Conference again. I will start with providing an overview in the presentation of Novanta and our strategy in high-growth markets. And then Robert Buckley, who's here with me, our CFO, will join me for a Q&A session.

Before I get into the meat of the presentation, I just wanted to turn your attention into our safe harbor statement. I will be making some forward-looking statements as well as refer to non-GAAP financial measures, and you can see the details of the reconsolidation (sic) [reconciliation] of our GAAP to non-GAAP financial measures on our website.

So moving on to Slide #3, the Novanta overview at a glance. We're about an $850 million revenue company, a technology provider of what we call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot